Current applications of molecular cytogenetic technologies

Hon Fong Louie Mark, Robert Jenkins, Wayne A. Miller

Research output: Contribution to journalReview article

17 Scopus citations

Abstract

This review discusses select current applications of fluorescent in situ hybridization (FISH) which may be of utility for the average clinical cytogenetic laboratory. Owing to the large number of men and women affected, the applications chosen to illustrate the use of FISH technology in cancer focus on two diseases: breast cancer and prostate cancer. The applicability of FISH to detect common aneuploidies, such as trisomy 21, trisomy 18, trisomy 13 and the sex chromosome aneuploidies in prenatal diagnosis, is discussed, as well as FISH for the detection of microdeletions and microduplications. Quality assurance/quality control issues and standards and guidelines relating to laboratory practices in molecular cytogenetic testing are reviewed.

Original languageEnglish (US)
Pages (from-to)47-56
Number of pages10
JournalAnnals of Clinical and Laboratory Science
Volume27
Issue number1
StatePublished - Jan 22 1997

ASJC Scopus subject areas

  • Microbiology
  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology
  • Molecular Biology
  • Hematology
  • Clinical Biochemistry
  • Medical Laboratory Technology

Fingerprint Dive into the research topics of 'Current applications of molecular cytogenetic technologies'. Together they form a unique fingerprint.

  • Cite this